473 related articles for article (PubMed ID: 22834861)
1. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
[TBL] [Abstract][Full Text] [Related]
2. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
[TBL] [Abstract][Full Text] [Related]
3. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
[TBL] [Abstract][Full Text] [Related]
4. Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures.
Palm F; Kleemann T; Dos Santos M; Urbanek C; Buggle F; Safer A; Hennerici MG; Becher H; Zahn R; Grau AJ
Eur J Neurol; 2013 Jan; 20(1):117-23. PubMed ID: 22788384
[TBL] [Abstract][Full Text] [Related]
5. Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation.
Hong HJ; Kim YD; Cha MJ; Kim J; Lee DH; Lee HS; Nam CM; Nam HS; Heo JH
Eur J Neurol; 2012 Feb; 19(2):284-90. PubMed ID: 21914056
[TBL] [Abstract][Full Text] [Related]
6. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
7. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Coppens M; Eikelboom JW; Hart RG; Yusuf S; Lip GY; Dorian P; Shestakovska O; Connolly SJ
Eur Heart J; 2013 Jan; 34(3):170-6. PubMed ID: 23018151
[TBL] [Abstract][Full Text] [Related]
8. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
[TBL] [Abstract][Full Text] [Related]
9. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
10. Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.
Poli D; Lip GY; Antonucci E; Grifoni E; Lane D
J Cardiovasc Electrophysiol; 2011 Jan; 22(1):25-30. PubMed ID: 20653814
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
12. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
[TBL] [Abstract][Full Text] [Related]
13. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.
Lip GY; Frison L; Halperin JL; Lane DA
Stroke; 2010 Dec; 41(12):2731-8. PubMed ID: 20966417
[TBL] [Abstract][Full Text] [Related]
14. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
[TBL] [Abstract][Full Text] [Related]
15. Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.
Esteve-Pastor MA; Marín F; Bertomeu-Martinez V; Roldán-Rabadán I; Cequier-Fillat Á; Badimon L; Muñiz-García J; Valdés M; Anguita-Sánchez M;
Intern Med J; 2016 May; 46(5):583-9. PubMed ID: 26929032
[TBL] [Abstract][Full Text] [Related]
16. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
Naccarelli GV; Panaccio MP; Cummins G; Tu N
Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of transesophageal echocardiography to confirm clinical utility of CHA2DS2-VASc and CHADS2 scores in atrial flutter.
Parikh MG; Aziz Z; Krishnan K; Madias C; Trohman RG
Am J Cardiol; 2012 Feb; 109(4):550-5. PubMed ID: 22133753
[TBL] [Abstract][Full Text] [Related]
18. Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation.
Willens HJ; Gómez-Marín O; Nelson K; DeNicco A; Moscucci M
J Am Soc Echocardiogr; 2013 Feb; 26(2):175-84. PubMed ID: 23253435
[TBL] [Abstract][Full Text] [Related]
19. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
[TBL] [Abstract][Full Text] [Related]
20. The CHA(2)DS(2)-VASc score reflects clinical outcomes in nonvalvular atrial fibrillation patients with an initial cardioembolic stroke.
Deguchi I; Hayashi T; Ohe Y; Kato Y; Nagoya H; Fukuoka T; Maruyama H; Horiuchi Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e343-6. PubMed ID: 23523201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
